Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000195201 | SCV000247672 | benign | not specified | 2016-11-15 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001537823 | SCV000526031 | likely benign | not provided | 2020-06-29 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000469821 | SCV000563654 | benign | Developmental and epileptic encephalopathy, 14; Autosomal dominant nocturnal frontal lobe epilepsy 5 | 2025-02-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002314823 | SCV000848374 | likely benign | Inborn genetic diseases | 2016-07-07 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV002269963 | SCV002555310 | benign | Developmental and epileptic encephalopathy, 14 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002269964 | SCV002555311 | benign | Autosomal dominant nocturnal frontal lobe epilepsy 5 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001537823 | SCV004010895 | likely benign | not provided | 2024-06-01 | criteria provided, single submitter | clinical testing | KCNT1: BP4, BP7, BS1 |
Athena Diagnostics | RCV000195201 | SCV005620914 | benign | not specified | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001537823 | SCV001928680 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001537823 | SCV001969151 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003907691 | SCV004724806 | likely benign | KCNT1-related disorder | 2019-06-20 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |